Sebastian Biedenkopf - Fresenius HR, Officer

All Insiders . USA . 
Stock . Fresenius SE Co . Stakeholders . Insider . Sebastian Biedenkopf
FSNUY Stock  USD 8.71  0.05  0.58%   

Insider

Sebastian Biedenkopf is HR, Officer of Fresenius SE Co
Age 59
Phone49 6172 608 2487
Webhttps://www.fresenius.com

Fresenius Management Efficiency

The company has return on total asset (ROA) of 0.0292 % which means that it generated a profit of $0.0292 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0793 %, meaning that it generated $0.0793 on every $100 dollars invested by stockholders. Fresenius' management efficiency ratios could be used to measure how well Fresenius manages its routine affairs as well as how well it operates its assets and liabilities.
Fresenius SE Co has accumulated 27.16 B in total debt with debt to equity ratio (D/E) of 0.89, which is about average as compared to similar companies. Fresenius SE has a current ratio of 1.29, suggesting that it is not liquid enough and may have problems paying out its financial obligations in time and when they become due. Debt can assist Fresenius until it has trouble settling it off, either with new capital or with free cash flow. So, Fresenius' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Fresenius SE sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Fresenius to invest in growth at high rates of return. When we think about Fresenius' use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

LLB BECONRamsay Health Care
N/A
Kelly HibbinsRamsay Health Care
N/A
Andrew JonesRamsay Health Care
49
Michael GremleyNova Leap Health
N/A
Alison DeBloisNova Leap Health
N/A
Colleen HarrisRamsay Health Care
54
John ScharioMedical Facilities
N/A
Martyn RobertsRamsay Health Care
55
William MayMedical Facilities
N/A
Doug MeagherRamsay Health Care
N/A
David WatsonMedical Facilities
57
Blake CurdMedical Facilities
N/A
AC DScRamsay Health Care
70
Kevin BlaylockMedical Facilities
N/A
Andrew WearneRamsay Health Care
N/A
Kah HongRamsay Health Care
50
KGaA, a health care company, provides products and services for dialysis, hospitals, and outpatient medical care. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Hhe, Germany. Fresenius operates under Medical Care Facilities classification in the United States and is traded on OTC Exchange. It employs 318647 people. Fresenius SE Co [FSNUY] is a Pink Sheet which is traded through a dealer network over-the-counter (OTC).

Management Performance

Return On Equity0.0793
Return On Asset0.0292

Fresenius SE Leadership Team

Elected by the shareholders, the Fresenius' board of directors comprises two types of representatives: Fresenius inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Fresenius. The board's role is to monitor Fresenius' management team and ensure that shareholders' interests are well served. Fresenius' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Fresenius' outside directors are responsible for providing unbiased perspectives on the board's policies.
Francesco Meo, Member of the Management Board - Fresenius Management SE and CEO of Fresenius Helios
Michael Sen, Pres CEO
Sara Hennicken, Chief Officer
Helen Giza, Member SE
Ernst Wastler, Member of the Management Board - Fresenius Management SE and CEO of Fresenius Vamed
Sebastian Biedenkopf, HR, Officer
Matthias Link, Sr Communications
Markus Georgi, Senior Vice President Investor Relations
Carla Kriwet, Members SE

Fresenius Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Fresenius a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity0.0793
Return On Asset0.0292
Profit Margin0.04 %
Operating Margin0.09 %
Current Valuation43.74 B
Shares Outstanding2.25 B
Price To Earning7.33 X
Price To Book0.71 X
Price To Sales0.38 X
Revenue37.52 B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
RSIRush Street Interactive
OKTAOkta Inc
BACBank of America

Additional Tools for Fresenius Pink Sheet Analysis

When running Fresenius' price analysis, check to measure Fresenius' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fresenius is operating at the current time. Most of Fresenius' value examination focuses on studying past and present price action to predict the probability of Fresenius' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fresenius' price. Additionally, you may evaluate how the addition of Fresenius to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY